McGorry plans to trial cannabis extract in kids

Prominent psychiatrist Professor Patrick McGorry is planning a trial of cannabis extract in children as young as 12 for treatment-resistant anxiety.

The early intervention pioneer says he is confident of getting ethics committee approval for the open-label pilot trial.

The plan is to trial capsules containing 400-800mg of cannabidiol in 30 people aged 12-25, who will be recruited from Headspace centres in North Melbourne.

Cannabidiol is the potentially therapeutic component of cannabis and does not contain the psychoactive ingredient tetrahydrocannabinol (THC).

Professor McGorry says there is some